Form 3: Initial Statement of Beneficial Ownership of Securities

This filing is an initial statement of beneficial ownership of securities filed by Kun Qian, Global Controller at CASI Pharmaceuticals, Inc. The filing details various stock options held by Mr. Qian, all of which are exercisable directly. These options pertain to the company's Ordinary Shares, with exercise prices ranging from $1.93 to $5.78 and expiration dates spanning from 2032 to 2034. Some options are fully vested, while others are performance-based and exercisable upon achievement of performance targets. The filing was signed on April 13, 2026, reporting on ownership as of March 18, 2026.